TR201917122A2 - Protei̇n i̇laçlarin enzi̇mati̇k yolla bi̇yopoli̇merlerle konjugasyonu - Google Patents

Protei̇n i̇laçlarin enzi̇mati̇k yolla bi̇yopoli̇merlerle konjugasyonu Download PDF

Info

Publication number
TR201917122A2
TR201917122A2 TR2019/17122A TR201917122A TR201917122A2 TR 201917122 A2 TR201917122 A2 TR 201917122A2 TR 2019/17122 A TR2019/17122 A TR 2019/17122A TR 201917122 A TR201917122 A TR 201917122A TR 201917122 A2 TR201917122 A2 TR 201917122A2
Authority
TR
Turkey
Prior art keywords
biopolymers
conjugation
protein drugs
enzymatic route
enzymatic
Prior art date
Application number
TR2019/17122A
Other languages
English (en)
Inventor
Göksu Kaya Özsan Ayşe
Fi̇li̇z Öner Ayşe
Original Assignee
Hacettepe Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hacettepe Ueniversitesi filed Critical Hacettepe Ueniversitesi
Priority to TR2019/17122A priority Critical patent/TR201917122A2/tr
Priority to PCT/TR2020/051004 priority patent/WO2021091511A2/en
Publication of TR201917122A2 publication Critical patent/TR201917122A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6955—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a plaster, a bandage, a dressing or a patch
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/02—Aminoacyltransferases (2.3.2)
    • C12Y203/02013—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Buluş, protein ilaçların enzimatik yolla biyopolimerler ile konjugasyonu ile konjugatların elde edilmesi ve bu konjugatları içeren yama yapıların oluşturulması ile ilgilidir.
TR2019/17122A 2019-11-05 2019-11-05 Protei̇n i̇laçlarin enzi̇mati̇k yolla bi̇yopoli̇merlerle konjugasyonu TR201917122A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/17122A TR201917122A2 (tr) 2019-11-05 2019-11-05 Protei̇n i̇laçlarin enzi̇mati̇k yolla bi̇yopoli̇merlerle konjugasyonu
PCT/TR2020/051004 WO2021091511A2 (en) 2019-11-05 2020-10-27 Conjugation of protein drugs with biopolymers by an enzymatic method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17122A TR201917122A2 (tr) 2019-11-05 2019-11-05 Protei̇n i̇laçlarin enzi̇mati̇k yolla bi̇yopoli̇merlerle konjugasyonu

Publications (1)

Publication Number Publication Date
TR201917122A2 true TR201917122A2 (tr) 2021-05-21

Family

ID=75849027

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17122A TR201917122A2 (tr) 2019-11-05 2019-11-05 Protei̇n i̇laçlarin enzi̇mati̇k yolla bi̇yopoli̇merlerle konjugasyonu

Country Status (2)

Country Link
TR (1) TR201917122A2 (tr)
WO (1) WO2021091511A2 (tr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7901711B1 (en) * 2006-04-17 2011-03-08 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
ITMI20061624A1 (it) * 2006-08-11 2008-02-12 Bioker Srl Mono-coniugati sito-specifici di g-csf
CA3138128C (en) * 2008-03-31 2024-02-13 Passport Technologies, Inc. Permeant delivery system and methods for use thereof

Also Published As

Publication number Publication date
WO2021091511A3 (en) 2021-06-17
WO2021091511A2 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
CY1124157T1 (el) Προσδετες δικυκλικου πεπτιδιου ειδικοι για μτ1-mmρ
CL2018003520A1 (es) Anticuerpos anti-b7-h3 y conjugados de anticuerpo y fármaco.
CY1119183T1 (el) Πεπτιδια λυσοσωμiκης στοχευσης και χρησεις αυτων
MX2020013169A (es) Conjugados de camptotecina.
PH12017502390A1 (en) Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof
BR112018075649A2 (pt) anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
CO2018008427A2 (es) Conjugado de enzimas terapéuticas
BR112018075651A2 (pt) anticorpos anti-cd98 e conjugados anticorpo fármaco
MX2021011997A (es) Enlazadores de conjugacion mejorados.
MX2017014056A (es) Construcciones dirigidas a complejos de peptido e7 del subtipo 16 del virus de papiloma humano (hpv16-e7)/complejo principal de histocompatibilidad (mhc) y sus usos.
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
BR112016024525A2 (pt) novos anticorpos anti-rnf43 e métodos de uso
MX2020010881A (es) Construcciones de anticuerpos anti-ror.
BR112018075630A2 (pt) anticorpos anti-cd98 e conjugados de fármaco de anticorpo
CO2020009737A2 (es) Composiciones de edb que se dirigen a il-12
BR112021015477A2 (pt) Anticorpos anti-cd228 e conjugados anticorpo-fármaco
BR112021025699A2 (pt) Anticorpos anti-mesotelina e imunoconjugados dos mesmos
WO2018191363A8 (en) Targeted combination therapy
MX2015012873A (es) Reticuladores quimicos.
TR201901977T4 (tr) Cxcr3 reseptörü modülatörleri olarak (r)-2-metil-piperazin türevleri.
PH12018500159A1 (en) Constructs targeting psa peptide/mhc complexes and uses thereof
WO2018136620A3 (en) Endosomal cleavable linkers
EA202190653A1 (ru) Конъюгаты связывающего белка с токсином, содержащие антрациклины, и их применение в иммуноонкологических целях
CL2022001196A1 (es) Conjugados anticuerpo-fármaco dirigidos a la claudina 18.2
WO2018057967A3 (en) Constructs targeting hiv peptide/mhc complexes and uses thereof